Glenview Trust’s Jazz Pharmaceuticals JAZZ Stock Holding History

Glenview Trust’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$834K	Hold	4,409	–	–	0.01%	308
2025 Q4	$750K	Hold	4,409	–	–	0.01%	315
2025 Q3	$581K	Sell	4,409 -3	-0.1%	-$360	0.01%	356
2025 Q2	$468K	Buy	4,412 +263	+6%	+$28.6K	0.01%	383
2025 Q1	$515K	Hold	4,149	–	–	0.01%	356
2024 Q4	$511K	Sell	4,149 -500	-11%	-$58.9K	0.01%	352
2024 Q3	$518K	Hold	4,649	–	–	0.01%	356
2024 Q2	$496K	Buy	4,649 +675	+17%	+$74.2K	0.01%	349
2024 Q1	$479K	Buy	3,974 +1,448	+57%	+$177K	0.01%	352
2023 Q4	$311K	Buy	2,526 +288	+13%	+$35.9K	0.01%	396
2023 Q3	$290K	Buy	+2,238	New	+$298K	0.01%	386
2023 Q1	–	Sell	-1,315	Closed	-$209K	–	448
2022 Q4	$209K	Buy	+1,315	New	+$193K	0.01%	416
2021 Q4	–	Sell	-2,875	Closed	-$375K	–	425
2021 Q3	$375K	Hold	2,875	–	–	0.01%	311
2021 Q2	$511K	Buy	2,875 +850	+42%	+$147K	0.02%	264
2021 Q1	$333K	Buy	+2,025	New	+$333K	0.01%	322

Other funds holding JAZZ

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Glenview Trust's JAZZ Position: Q1 2026 in Review

Glenview Trust held its Jazz Pharmaceuticals (JAZZ) position steady in Q1 2026 at 4,409 shares worth $834K. The position accounts for 0.01% of the portfolio, ranked #308.

Glenview Trust first reported a position in JAZZ in Q1 2021 and has held it in 15 quarters since. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

Glenview Trust held 4,409 shares of Jazz Pharmaceuticals worth $834K as of Q1 2026.
Glenview Trust left its Jazz Pharmaceuticals share count unchanged in Q1 2026.
Jazz Pharmaceuticals made up 0.01% of Glenview Trust's portfolio in Q1 2026, its #308 holding.
Glenview Trust first reported a position in Jazz Pharmaceuticals in Q1 2021 and has held it in 15 quarters since.
570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Glenview Trust's 13F filing for Q1 2026, filed 8 May 2026.